Skip to content

Clinical trials

Completed Thromboembolism trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Status: Completed Country / region: Netherlands Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20042
20064
20081
20092
20122
20131
20143
20151
20162
20181
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim6
Bayer5
Janssen Research & Development, LLC2
Abbott Medical Devices1
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Astellas Pharma Inc1
Boston Scientific Corporation1
Daiichi Sankyo1
European Organisation for Research and Treatment of Cancer - EORTC1
Inari Medical1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism22
Thrombosis6
Stroke5
Venous Thromboembolism5
Atrial Fibrillation4
Pulmonary Embolism4
Venous Thrombosis4
Ischemic Attack, Transient2
Breast Neoplasms1
Breast Neoplasms, Male1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.